May 06, 2021 11:27 AM IST
What does the US decision to support an initiative at WTO for temporary waiver of patent protection for COVID-19 vaccines mean for India? Below is a primer.
- May 05, 2021 12:43 PM IST
Companies other than Bharat Biotech must be given contracts to manufacture the indigenously developed Covaxin in bulk. This is the time to open licensing to any company that wants to produce vaccines and for anyone who wants to take a jab, per doctors.
- May 05, 2021 10:24 AM IST
In September 2020, the Bill and Melinda Gates Foundation provided $150 million to the Pune-based vaccine-maker to fund the additional 10 crore COVID-19 vaccine doses.
- May 04, 2021 02:23 PM IST
So far, 15.5 crore doses have been administered since January and the central and state governments along with the private sector aim to get 30 crore more doses in three months until July.
- May 03, 2021 03:25 PM IST
As on date, against the last order of 10 crore doses for supplies of Covishield vaccine, 8.744 crore doses have been delivered till May 3, the ministry said, adding, media reports alleging that the Centre has not placed any fresh order for COVID-19 vaccines are "incorrect and not based on facts".
- May 03, 2021 02:11 PM IST
The Serum Institute has been maligned by politicians and critics over the vaccine shortages, Adar Poonawalla tells Financial Times. "I have been victimised very unfairly and wrongly."
- May 02, 2021 08:32 AM IST
Serum Institute of India CEO Adar Poonawalla also confirmed that he had “an excellent meeting” with all partners and stakeholders in the United Kingdom.
- May 01, 2021 10:42 AM IST
Poonawalla said last week that the Serum Institute would be able to raise its monthly output to 100 million doses by July, later than a previous timeline of end-May.
- Apr 30, 2021 11:10 AM IST
The cumulative number of COVID-19 vaccine doses administered in the country stands at 15,21,05,563.
- Apr 30, 2021 08:16 AM IST
BMC said the vaccination drive for the 18-44 age group, scheduled to begin from May 1 earlier, was likely to be deferred.
- Apr 29, 2021 12:28 PM IST
The Centre has decided to open up the vaccination drive for everyone above 18 from May 1 onwards.
- Apr 28, 2021 08:01 PM IST
Poonawalla, 40, is one of the key players in the country's fight against the COVID-19 pandemic.
- Apr 28, 2021 06:48 PM IST
The state government announced that of the one crore vaccines to be purchased, 70 lakh doses will be Covishield and 30 lakh Covaxin. The said number of doses will be procured between May and July for Rs 483 crore.
- Apr 28, 2021 05:33 PM IST
The vaccine manufactured by Serum Institute of India was earlier priced at Rs 400 per dose for the state governments.
- Apr 28, 2021 04:36 PM IST
The study also reports a significant decrease of infection rates from 12 to 21 days after the first dose of the Pfizer (58 percent reduction) and AstraZeneca (39 percent reduction) vaccines compared to a control group. The drop in infection at least 21 days after the first dose for Pfizer is 69 percent and for AstraZeneca 60 percent, according to the study.
- Apr 28, 2021 07:34 AM IST
Coronavirus News Highlights: Registering a steady increase, the active cases have risen to 29,78,709, comprising 16.55 percent of the total infections
- Apr 27, 2021 10:53 PM IST
Anurag Agrawal, the Director of the Institute of Genomics and Integrative Biology (IGIB), said the study on effectiveness of the available vaccines on the B.1.617 variant of SARS-CoV2 suggests that post vaccination, the infections are milder.
- Apr 27, 2021 03:30 PM IST
If such public money has been used in the development of COVID-19 vaccines, there should be enough transparency in the pricing of these vaccines, too
- Apr 27, 2021 01:10 PM IST
As a deadly second wave of COVID-19 continues, Nepal has also requested ventilators, oxygen cylinders and medical supplies from India. Though Nepal has approved a Chinese vaccine, it is not recognised by the WHO and there are concerns over its safety and efficacy.
- Apr 26, 2021 10:35 AM IST
Given improved demand scenario in developed markets and ebbing of health crises elsewhere, India’s export oriented sectors – IT, pharma and chemicals – are expected to outperform in the short to medium run
- Apr 26, 2021 10:30 AM IST
Countries having high coverage of COVID jabs have seen a sharp decline in death rates as the vaccination coverage picked up
- Apr 24, 2021 04:18 PM IST
"Covishield is the most affordable COVID-19 vaccine available in the market today. The initial prices were kept very low globally as it was based on advance funding given by those countries for at-risk vaccine manufacturing," Serum India said in a statement.
- Apr 23, 2021 11:16 AM IST
On April 19, the central government announced a major shift in its Covid-19 vaccination strategy. Moneycontrol takes a look at what these changes mean.
- Apr 22, 2021 10:14 AM IST
The year that started out on a sizzling note has fizzled out, with only the pharma sector - naturally - emerging as the top performer, quite like 2020
- Apr 21, 2021 05:36 PM IST
SII will never take advantage of the pandemic, we are losing Rs 150 per dose now, says Poonawalla.